Jay Hsu, PhD

  • 2Articles
  • 12.3KReads
  • 2013Active
  • 8Collaborators
  • 227Citations

About

Jay Hsu, PhD, has published research on the treatment of schizophrenia and schizoaffective disorders, focusing on the effectiveness of lurasidone. The work includes studies evaluating lurasidone following acute treatment with various antipsychotics and its use in patients switched from other antipsychotic medications. These articles appeared in 2013 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders).

Publications

JCP
Original Research

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study

March 13, 2013

, , , et al
JCP
Original Research

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

January 15, 2013

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe